02335

Dr. Weiping Yu is Senior VP & Executive Director of Shaanxi Micot Pharmaceutical Technology Co. Ltd. from August 2019. Dr. Yu joined the Shaanxi Micot Pharmaceutical Technology Co. Ltd. in July 2017. He is primarily responsible for the strategic planning, overseeing the CMC activities and overall operation management of our Group. Dr. Yu was first appointed as an executive Director and senior vice president in August 2019 and served until now. Dr. Yu has over 40 years of experience in pharmaceutical research, development and executive management. Dr. Yu served as Senior Director of Product and Process Development at Celsion Corporation, USA, a U.S.-based biopharmaceutical company principally engaged in the R&D of oncology therapeutics. From September 2010 to June 2014, Dr. Yu served as Vice President of research and subsequently from June 2014 to June 2017, he held the position of Chief Executive Officer and President in Lipont Pharmaceuticals (Canada), a biopharmaceutical company engaged in the research, development and production of pharmaceutical products. Dr. Yu obtained a bachelor ’s degree from Shanghai University of Traditional Chinese Medicine from 1978 to 1982. He obtained a master’s degree from Shanghai Institute of Pharmaceutical Industry from 1982 to 1984. He further obtained a doctoral degree from University of Paris-Sud from 1987 to 1990.